OpenFilings

Axsome Therapeutics, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-02-23

Time Filed08:10:48

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
AXSOME THERAPEUTICS, INC. AMENDED AND RESTATED 2015 OMNIBUS INCENTIVE COMPENSATI
AXSOME THERAPEUTICS, INC. INSIDER TRADING COMPANY
SUBSIDIARIES OF THE COMPANY
CONSENT OF DELOITTE & TOUCHE LLP
CONSENT OF ERNST & YOUNG LLP
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A
EX-32.1
EX-32.2
AXSOME THERAPEUTICS, INC. DODD-FRANK CLAWBACK POLICY
Filing on SEC Edgar